Trevi Therapeutics
TRVI
TRVI
153 hedge funds and large institutions have $627M invested in Trevi Therapeutics in 2025 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 65 increasing their positions, 31 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 137 → 153 (+16)
6.59% more ownership
Funds ownership: 91.16% → 97.75% (+6.6%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Holders
153
Holding in Top 10
7
Calls
$7.77M
Puts
$3.73M
Top Buyers
| 1 | +$26.5M | |
| 2 | +$24.8M | |
| 3 | +$18M | |
| 4 |
O
OrbiMed
New York
|
+$13.6M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$12.4M |
Top Sellers
| 1 | -$18.8M | |
| 2 | -$10.5M | |
| 3 | -$4.32M | |
| 4 |
Millennium Management
New York
|
-$4.14M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.98M |